ArticleCancer chemotherapy and pharmacology2011

The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention.

Susan K Peirce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.